Tagrisso® (osimertinib)
for Lung Cancer

Tagrisso (osimertinib) is used to treat adults with non-small cell lung cancer (NSCLC) that has certain abnormal EGFR genes. It helps prevent cancer from returning after surgery, treats locally advanced cancer after chemo and radiation, and is used as a first treatment for metastatic NSCLC, alone or with chemo. It also treats metastatic NSCLC after other EGFR treatments fail. Tagrisso targets EGFR mutations to block cancer cell growth and promote cell death.

Heart